Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter Completed Phase 1 Trials for Carboplatin (DB00958)

Also known as: Transitional cell cancer of the renal pelvis and ureter recurrent / Renal pelvis and ureter transitional cell cancer recurrent / Renal pelvis and ureteric cancer recurrent transitional cell / Renal pelvis and ureteral cancer transitional cell recurrent / Renal pelvis and ureteric cancer transitional cell recurrent

IndicationStatusPhase
DBCOND0028816 (Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00004074Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuTreatment